In an interview with Neue Zuercher Zeitung, Novartis (NVS) CEO Vas Narasimhan said the company is looking into ways to propose price cuts to U.S. President Donald Trump, Myriam Balezou of Bloomberg reports. “We’re working with the government to find constructive solutions so Americans pay less for their medicines,” Narasimhan said, according to Bloomberg.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVS:
- Tesla CEO buys shares, China says Nvidia broke antitrust law: Morning Buzz
- Monte Rosa’s Stock (GLUE) Skyrockets on $5.7B Deal with Novartis
- Monte Rosa Therapeutics announces collaboration with Novartis
- Trump Weekly: Trump signs pharma order, FTC opens inquiry into AI chatbots
- Microsoft, OpenAI sign MOU for next phase of partnership: Morning Buzz